Madrone Advisors’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.8M | Sell |
16,762,216
-6,629,699
| -28% | -$8.22M | 2.89% | 4 |
|
|
2025
Q1 | $27.6M | Hold |
23,391,915
| – | – | 4.62% | 4 |
|
|
2024
Q4 | $42.8M | Hold |
23,391,915
| – | – | 8.16% | 4 |
|
|
2024
Q3 | $39.8M | Hold |
23,391,915
| – | – | 6.35% | 4 |
|
|
2024
Q2 | $32M | Buy |
23,391,915
+5,800,000
| +33% | +$7.95M | 5.63% | 3 |
|
|
2024
Q1 | $66M | Hold |
17,591,915
| – | – | 9.04% | 3 |
|
|
2023
Q4 | $173M | Buy |
17,591,915
+1,175,982
| +7% | +$11.5M | 21.5% | 2 |
|
|
2023
Q3 | $137M | Hold |
16,415,933
| – | – | 29.47% | 2 |
|
|
2023
Q2 | $218M | Hold |
16,415,933
| – | – | 38.11% | 2 |
|
|
2023
Q1 | $190M | Hold |
16,415,933
| – | – | 35.03% | 2 |
|
|
2022
Q4 | $134M | Buy |
+16,415,933
| New | +$134M | 25.9% | 2 |
|